NO20055098L - Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser - Google Patents

Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser

Info

Publication number
NO20055098L
NO20055098L NO20055098A NO20055098A NO20055098L NO 20055098 L NO20055098 L NO 20055098L NO 20055098 A NO20055098 A NO 20055098A NO 20055098 A NO20055098 A NO 20055098A NO 20055098 L NO20055098 L NO 20055098L
Authority
NO
Norway
Prior art keywords
treatment
affective disorders
compound
dihydrocarbamazepine
hydroxy
Prior art date
Application number
NO20055098A
Other languages
English (en)
Other versions
NO20055098D0 (no
Inventor
Markus Schmutz
Ferenc Martenyl
Stefanie Zechner
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20055098D0 publication Critical patent/NO20055098D0/no
Publication of NO20055098L publication Critical patent/NO20055098L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

Sammendrag Den foreliggende oppfinnelsen vedrører en fremgangsmåte for behandling, inkludert vedlikeholdsbehandling av affektive forstyrrelser, som omfatter å. administrere, spesielt hver 20. til 28. time, en terapeutisk effektiv mengde, spesielt en mengde på mellom omtrent 500 og omtrent 3 000 mg, av en forbindelse med formel I der R1 står for hydrogen eller C1-C3-alkylkarbonyl, til et subjekt; anvendelse av en forbindelse av I eller et farmasøytisk akseptabelt salt derav for fremstilling av en farmasøytisk sammensetning for behandling av affektive forstyrrelser; en kombinasjon som omfatter (a) en forbindelse med formel I og (b) i det minste en forbindelse valgt fra gruppen bestående av litium, divalproex, konvensjonelle, anti-psykotiske midler, atypiske, antipsykotiske midler, lamotrigin og antidepressive midler; og anvendelsen av slike kombinasjoner for behandling av affektive forstyrrelser.
NO20055098A 2003-04-02 2005-11-01 Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser NO20055098L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45986403P 2003-04-02 2003-04-02
PCT/EP2004/003590 WO2004087168A1 (en) 2003-04-02 2004-04-01 Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders

Publications (2)

Publication Number Publication Date
NO20055098D0 NO20055098D0 (no) 2005-11-01
NO20055098L true NO20055098L (no) 2005-12-22

Family

ID=33131906

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055098A NO20055098L (no) 2003-04-02 2005-11-01 Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser

Country Status (18)

Country Link
US (1) US20070010508A1 (no)
EP (1) EP1613329A1 (no)
JP (1) JP2006522064A (no)
KR (1) KR20050121235A (no)
CN (1) CN1767834A (no)
AU (1) AU2004226827B2 (no)
BR (1) BRPI0409151A (no)
CA (1) CA2520828A1 (no)
IS (1) IS8094A (no)
MA (1) MA27762A1 (no)
MX (1) MXPA05010614A (no)
NO (1) NO20055098L (no)
NZ (1) NZ542555A (no)
RU (1) RU2367440C2 (no)
TN (1) TNSN05246A1 (no)
TW (1) TW200502222A (no)
WO (1) WO2004087168A1 (no)
ZA (1) ZA200507742B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX366496B (es) * 2005-05-06 2019-07-11 Bial Portela & Ca Sa Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso.
EP2380573B1 (en) * 2005-05-06 2015-02-25 Bial-Portela & CA, S.A. Eslicarbazepine acetate and methods of use
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
US7855279B2 (en) 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
GB2437078A (en) 2006-04-11 2007-10-17 Portela & Ca Sa 10-Acyloxy-5H-dibenzo[b,f]azepine-5-carboxamides & their asymmetric hydrogenation to the chiral 10,11-dihydro derivatives
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
EP2254598B1 (en) * 2008-02-13 2013-07-10 Targacept, Inc. Combination of alpha 7 nicotinic agonists and antipsychotics
US8703717B2 (en) 2009-02-03 2014-04-22 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
DK3178835T3 (da) 2009-02-03 2019-06-24 Amunix Pharmaceuticals Inc Forlængede rekombinante polypeptider og sammensætninger omfattende samme
US8680050B2 (en) 2009-02-03 2014-03-25 Amunix Operating Inc. Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same
US9849188B2 (en) 2009-06-08 2017-12-26 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
CN102188432B (zh) * 2011-04-07 2012-05-23 江立富 一种用于防治癫痫的药物
JP2013237676A (ja) * 2013-06-26 2013-11-28 Bial-Portela & Ca Sa 酢酸エスリカルバゼピン及び使用方法
US9896451B2 (en) 2013-09-06 2018-02-20 Nippon Soda Co., Ltd. Method for producing endo-9-azabicyclo[3.3.1]nonan-3-ol derivative
EP3064490A1 (en) 2015-03-06 2016-09-07 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of eslicarbazepine and eslicarbazepine acetate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605897A (en) * 1991-04-23 1997-02-25 Eli Lilly And Company 2-methyl-thieno-benzodiazepine
PT101732B (pt) 1995-06-30 1997-12-31 Portela & Ca Sa Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
DE10036289A1 (de) 2000-07-26 2002-02-07 Bosch Gmbh Robert Elektronisch kommutierte elektrische Maschine, insbesondere Motor
IL161700A0 (en) * 2001-11-12 2004-09-27 Novartis Ag Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain

Also Published As

Publication number Publication date
TW200502222A (en) 2005-01-16
BRPI0409151A (pt) 2006-03-28
JP2006522064A (ja) 2006-09-28
RU2367440C2 (ru) 2009-09-20
ZA200507742B (en) 2008-07-30
US20070010508A1 (en) 2007-01-11
RU2005133665A (ru) 2006-06-10
NO20055098D0 (no) 2005-11-01
IS8094A (is) 2005-10-27
CA2520828A1 (en) 2004-10-14
NZ542555A (en) 2009-03-31
MXPA05010614A (es) 2005-11-23
AU2004226827B2 (en) 2008-04-03
MA27762A1 (fr) 2006-02-01
CN1767834A (zh) 2006-05-03
WO2004087168A1 (en) 2004-10-14
KR20050121235A (ko) 2005-12-26
AU2004226827A1 (en) 2004-10-14
EP1613329A1 (en) 2006-01-11
TNSN05246A1 (en) 2007-06-11

Similar Documents

Publication Publication Date Title
NO20062691L (no) Azabicykliske heterocykler som cannabinoide reseptormodulatorer
NO20062689L (no) Azabisykliske heterosykler som modulatorer for kannabinoidreseptorer
NO20062704L (no) Azabicykliske heterocykler som cannabinoide reseptormodulatorer
SE0302760D0 (sv) New compounds
NO20045072L (no) Tablett med hoyt medikamentinnhold
NO20082496L (no) Pyrazinderivater
MXPA04012998A (es) Modulares de receptores nucleares de hormonas esteroideas triciclicos.
NO20063382L (no) Nye kinolinderivater
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
DE69521424D1 (de) Benzofuran derivate und ihre verwendung als inhibitoren der knochenresorption
TW200726765A (en) Triazolopyridine cannabinoid receptor 1 antagonists
TW200718418A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
EA200601194A1 (ru) Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
EE05103B1 (et) Famatseutilised kompositsioonid, mis sisaldavad asetidiini derivaate, asetidiini derivaadid ja nende valmistamise meetodid
NO20073730L (no) Amidderivater
NO20081844L (no) Terapeutiske forbindelser
GEP20094727B (en) Oxyindole derivatives as 5ht4 receptor agonists
NO20050134L (no) Difenylazetidioner substituert med syregrupper, fremgangsmate for fremstilling av disse, medikamenter inneholdende disse forbindelser og deres anvendelse
TNSN05246A1 (en) Use of 10-hydroxy-10, 11-dihydrocarbamazepine derivatives for the treatment of affective disorders
NO20040881L (no) Orale antidiabetes midler.
NO20032261L (no) Medisinske preparater
HUP0104963A2 (hu) Bőrbetegségek kezelésére szolgáló készítmények
CA2314154A1 (en) Azepine or larger medium ring derivatives and their use as pharmaceuticals
NO308654B1 (no) Amid-derivater, fremgangsmÕter og mellomprodukter for fremstilling derav, deres anvendelse og farmasøytiske blandinger som inneholdende dem
NO20004405L (no) Farmasøytisk sammensetning for profylakse og terapi av sykdommer forbundet med okulær-fundus-vev cytopati

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application